Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Assets (2016 - 2026)

Veracyte's Current Assets history spans 14 years, with the latest figure at $488.4 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 31.19% to $488.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $488.4 million, a 31.19% increase, with the full-year FY2025 number at $488.4 million, up 31.19% from a year prior.
  • Current Assets hit $488.4 million in Q4 2025 for Veracyte, up from $449.2 million in the prior quarter.
  • Over the last five years, Current Assets for VCYT hit a ceiling of $488.4 million in Q4 2025 and a floor of $229.3 million in Q3 2021.
  • Historically, Current Assets has averaged $315.5 million across 5 years, with a median of $288.0 million in 2023.
  • The widest YoY moves for Current Assets: up 115.04% in 2021, down 38.08% in 2021.
  • Tracing VCYT's Current Assets over 5 years: stood at $243.1 million in 2021, then rose by 2.28% to $248.6 million in 2022, then increased by 14.88% to $285.6 million in 2023, then soared by 30.34% to $372.3 million in 2024, then surged by 31.19% to $488.4 million in 2025.
  • Business Quant data shows Current Assets for VCYT at $488.4 million in Q4 2025, $449.2 million in Q3 2025, and $414.7 million in Q2 2025.